Skip to main content
An official website of the United States government

Funded Grants

PI Name Sort descending PI Organization Title Grant Number Initiative Program Official
Cai, Long

California Institute Of Technology
United States

Understanding the role of tumor microenvironment in low grade glioma progression to malignancy 1U01CA294551-01 Sidney Fu, M.D.
Cantuaria, Guilherme

Northside Hospital Atlanta
United States

Georgia NCI Community Oncology Research Program (GA NCORP) 5UG1CA189997-11 Vanessa A. White, M.P.H.
Cao, Shugeng

University Of Hawaii At Hilo
United States

Discovery of novel natural TEAD inhibitors for the chemoprevention of liver tumors 5UG3CA290375-02 Altaf Mohammed, Ph.D.
Cao, Yin

Washington University
United States

PROSPECT-Global Consortium and Risk Factor Discovery 1OT2CA297576-01 Asad Umar, D.V.M., Ph.D.
Cao, Weidan

Ohio State University
United States

Treatment-Related Cardiotoxicity Risk Prediction for Breast Cancer Patients with a Multimodal AI-based System 1R01CA301579-01 Eileen Dimond, R.N., M.S.
Carlson, Jay W

Ozark Health Ventures, Llc
United States

Ozark Health Ventures LLC dba Cancer Research for the Ozarks (CRO) 5UG1CA189822-11 Vanessa A. White, M.P.H.
Carson, Tiffany Lashaun

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Determining the structural- and functional-level effects of diet-specific interventions on the gut microbiota of a diverse sample of Southern United States adults 5R01CA253219-05 Young Kim, Ph.D.
Castilla, Lucio H.

Univ Of Massachusetts Med Sch Worcester
United States

Study of tyrosine kinase inhibitors as preventive therapy in RUNX1-FPD 1U01CA296350-01 Marjorie Perloff, M.D.
Castro, Cesar M

Massachusetts General Hospital
United States

Composing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approach 5U01CA279858-02 Christos Patriotis, Ph.D., M.Sc.
Caulin, Carlos

University Of Arizona
United States

Genetic Alterations That Confer High Risk to Oral Premalignant Lesions 5R01CA274857-03 PA-20-185 (Parent R01 Clinical Trial Not Allowed)